StockTipsArenaBeta

BUY Mankind Pharma Limited — Kotak Securities

BUYMankind Pharma Limited
Mankind Pharma share price target & all analyst calls

byKotak SecuritiesHorizon: NA (inferred 1 year)27 Oct 2026via CNBC Awaaz.

Entry₹2,358.5Inferred
Target₹3,035
Total upside +28.68%
Stop lossNot given
CMP₹2,502.5Just now
Active+6.11%+21.28%upside left 12 mo left
Follow Kotak Securities for new calls(89% target hit, 18 closed calls)Get alertsWatch MANKIND for new buy/sell callsGet alertsSee 9 other Long-term calls on MANKINDSee 132 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 27 Oct, 4:06 pm IST
23 supporting9 neutral3 opposing
Supports the BUY call (23)

Mankind Pharma shares jump 8% as Q2 profit rises 38% to Rs 716 crore

NewsEt-Markets·27 Oct · today

(opens in new tab)

Mankind Pharma Shares Jump Nearly 8% After Q2 Profit Rises 39%

NewsNdtv-Profit·27 Oct · today

(opens in new tab)

Mankind Pharma Q2 profit rises 38% to Rs 716 crore

NewsEt-Markets·27 Oct · today

(opens in new tab)

5 other SEBI-registered advisors have active long-term BUY calls on this stock, with 2 issued in the last 14 days

Advisor consensus · same horizon·27 Oct · today

Mankind Pharma Q2 profit jumps 39% to ₹712 crore as revenue rises 17%

NewsCnbc-Tv18·26 Oct · yesterday

(opens in new tab)
Neutral / worth noting (9)

Mankind Pharma Q2 Review: Export Momentum Continues; Systematix Maintains 'Hold'; Check Target Price

NewsNdtv-Profit·27 Oct · today

(opens in new tab)

Mankind Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

NSE · Outcome of Board Meeting·26 Oct · yesterday

(opens in new tab)

Mankind Pharma To Give Rs 1 Crore To Flydubai Captain Smit Machchhar, Family For Averting Flight Disaster

NewsNdtv-Profit·3 Oct · 3w ago

(opens in new tab)
Weighs against the BUY call (3)

Mankind Pharma auditor resigns as subsidiary Bharat Serums enters liquidation

NewsGoogle News·28 Sept · 4w ago

(opens in new tab)

Mankind Pharma's subsidiary Bharat Serums and Vaccines sees auditor resignation amid liquidation

NewsGoogle News·28 Sept · 4w ago

(opens in new tab)

1 other SEBI-registered advisor has an active long-term SELL call on this stock

Advisor consensus · same horizon·31 Jul · 3mo ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Mankind Pharma

All analyst calls on Mankind Pharma

More from Kotak Securities

Every call and its outcome